[Effects of the new peptide anxiolytic drug selank on the cardiovascular system functioning and respiration in cats].
The effects of the new heptapeptide anxiolytic drug selank (300 mg/kg, i.v.) on the arterial pressure (AP), cerebral blood flow, heart rhythm, respiration, and the AP depression induced by acetylcholine injections was recorded in narcotized male cats. Selank produced a 32 +/- 4.3% decrease in the AP for the first 1-3 min after injection. The drug also induced a 24 +/- 2.8% increase in the cerebral blood flow for the first 5 - 10 min upon injection and then the blood flow was gradually restored on the initial level. The heart rate and the respiratory rate were not affected by the drug injections. Nor did selank influence the AP depression in response to the acetylcholine introduction.
Gan'shina
T S
TS
Kozlovskiĭ
I I
II
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002531:Cerebellum / Q000098:blood supply*; D006339:Heart Rate / Q000187:drug effects*; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects*; D013268:Stimulation, Chemical
D014151:Anti-Anxiety Agents; D009842:Oligopeptides; C100827:TP 7